• Andrew Toyin Olagunju College of Medicine, University of Lagos
  • Olasimbo Adenike Ogundipe Health Service Commission, Lagos State
  • Tinuke Oluwasefunmi Olagunju Health Service Commission, Lagos State
  • Oluseyi Ayodeji Campbell College of Medicine, University of Lagos
  • Olatunji Francis Aina College of Medicine, University of Lagos
  • Alani Sulaimon Akanmu College of Medicine, University of Lagos


Introduction: There are good pointers from literature to the detrimental impacts of psychoactive substance use in HIV/AIDS patients. This study aimed at investigating the prevalence, types and demographic correlates of psychoactive substance use among people living with HIV/AIDS.

Methods: The study participants consisted of 295 adults with HIV/AIDS and were interviewed with a designed questionnaire that consisted of two parts. The first part contained questions to elicit socio-demographic and treatment related information of the participants, while the second part focused on psychoactive substance use.

Results: The mean (SD) age of participants was 37.6 (±8.6) years, and majority (61.0%) of them were made up of females. Most of the subjects were married, 181 (61.4%) and employed 174 (59.0%). Of the total participants, 64 (21.7%) reported  use of a form of psychoactive substance, among which the largest proportion (19.3%) reported use of alcohol, 1.4% use cannabis while 1% admitted to use of nicotine. Following regression analyses, being male (Odds Ratio =2.38; 95% Confidence Interval: 95% CI = 1.26 - 4.49; p=0.008) and increasing educational attainment (Odds Ratio = 1.62; 95% CI: 1.07 - 2.45; p=0.02) correlated positively with psychoactive substance use, while being single (Odds Ratio = 0.59; 95% CI: 0.35 - 0.99; p=0.047) correlated negatively.

Conclusion: Proactive and targeted intervention strategies against psychoactive substance use among people living with HIV/AIDS using what is known about vulnerability are implied. Further research on the complex relationship between HIV/AIDS and psychoactive substance use is indicated.


Keywords: Demographic Correlates; HIV/AIDS; Nigerians; Prevalence; Psychoactive Substance


Author Biographies

Andrew Toyin Olagunju, College of Medicine, University of Lagos

Psychiatry, Senior Lecturer

Olasimbo Adenike Ogundipe, Health Service Commission, Lagos State

Consultant Psychiatrist

Tinuke Oluwasefunmi Olagunju, Health Service Commission, Lagos State

Senior Medical Officer (Infectious Diseases Hospital)

Oluseyi Ayodeji Campbell, College of Medicine, University of Lagos

APIN   Laboratory, Central Research Laboratory

Olatunji Francis Aina, College of Medicine, University of Lagos

Associate Professor, Department of Psychiatry

Alani Sulaimon Akanmu, College of Medicine, University of Lagos

Professor, Depaertment of Haematology and Blood Transfusion


. UNAIDS. Epidemiological fact sheets on HIV/AIDS- Nigeria. 2014 (Retrieved on 21/07/15) –The Global HIV/AIDS Epidemics. 2014 (Retrived 25/07/15).

Abdool R, Sulliman FT, Dhanoo MI. The injecting drug use and HIV/AIDS nexus in the Republic of Mauritius. African Journal of Drug and Alcohol Studies 2006; 5(2):107-16.

Fischer JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review a meta-analysis of African studies. Sexually Transmitted Diseases, 2007;34(11):856-63.

Nijhawan A, Kim S, Rich JD. Management of HIV infection in patients with substance use problems. Curr Infect Dis Resp. 2008;10(5):432-38.

Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Research and Treatment. 2012;18: 124 –32

Ibrahim AW, Sale S. Prevalence, Predictors and Patterns of Psychoactive Substance use among HIV seropositive adults at Aminu Kano Teaching Hospital Kano, North Western Nigeria. Int. J. Med. Med. Sci. 2014; Vol. 1(7): 81-90

Doku D. Substance use and risky sexual behaviours among sexually experienced Ghanaian youth. BMC Public Health, 2012;12, 571.

Olisah VO, Adekeye O, Sheikh TL, Yusuf AJ. Alcohol-related problems and high risk sexual behaviour in patients with HIV/AIDS attending medical clinic in a Nigerian university teaching hospital. African Journal of Drug & Alcohol Studies. 2009;8(1):17-22

Purohit V, Rapaka RS, Rutter J, Shurtleff D. Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs. Journal of Neuroimmune Pharmacology 2012; 7(3), 519 - 23.

Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, Dam JV. Adherence to antiretroviral therapy and its determinants amongst HIV patients in India. Indian J Med Res. 2008; 127:28 - 36.

Klinkenberga WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care 2004;Vol.16, S1, pages 22-42 DOI: 10.1080/09540120412331315303

Sohler NL, Wong MD, Cunningham WE, Cabral H, Drainoni ML, Cunningham CO. Type and pattern of illicit drug use and access to health care services for HIV-infected people. AIDS Patient Care STD, 2007; 21 Suppl 1, 568 - 576.

Bartlett JA. Addressing the challenges of adherence. Journal of Acquired Immune Deficiency Syndromes. 2002;29(1):S2–S10

Braitstein PI, Li K, Kerr T, Montaner JS, Hogg RS, Wood E. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone. AIDS Care. 2006; 18(7):690-3.

Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasala RS, Lam MN, et al. Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS. 2004; 18:S19–S25.

Fleiss JL Statistical Methods for Rates and Proportions, 2nd ed., John Wiley and sons, New York. 1981; pp. 17 (Chapter 3).

Araoye M.O, Research Methodology with Statistics for Health and Social Sciences, Nathadex publishers, Ilorin, Nigeria, 2004, pp. 117–20.

Olagunju AT, Ogundipe OA, Erinfolami AR, Akinbode AA, Adeyemi JD. Toward the integration of comprehensive mental health services in HIV care: An assessment of psychiatric morbidity in HIV positive individuals in sub-Saharan Africa. AIDS Care, 2013; 25(9):1193-198

Olagunju AT, Ogundipe OA, Olagunju TO, Adeyemi JD A multi-dimensional assessment of quality of life among attendees of a West African HIV clinic and its use in tracking outcome. HIV & AIDS Review 2013;12(3):63-67 DOI: 10.1016/j.hivar.2013.07.003

Ogundipe OA, Olagunju AT, Adeyemi JD Suicidal Ideation among attendees of a West African HIV Clinic. Archives of Suicide Research. 2015; 19 (1):103-16. doi:10.1080/13811118.2014.915776. PMID:25058473

Spitzer RL, Williams Gibbon JB., Structured Clinical Interview for DSM-III-R–Patient Version. New York New York State Psychiatric Institute 1987.

McLellan AT, Luborsky L, Woody GE, O’Brien CP An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disorders, 1980;168 (1):26-33.

SPSS-17.0.1 The Statistical Package for Social Sciences version 17.0. Chicago, IL: SPSS Inc. 2008.

Yunusa MA, Obembe A, Ibrahim T, Njoku CH. Prevalence and specific psychosocial factors associated with substance use and psychiatric morbidity among patients with HIV infection at Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria. African Journal of Drug and Alcohol Studies. 2011; 10(1):11-16.

Goar GS, Audu MD, Agbir MT, Dochalson D. Prevalence and sociodemographic correlates of alcohol use disorders among HIV patients. African Journal of Drug and Alcohol Studies, 2011; 10(1), 41-7.

Gureje O, Degenhardt L, Olley B, Uwakwe R, Udofia O, Wakil A, Adeyemi O, Bohnert KM, Anthony JC. A descriptive epidemiology of substance use and substance use disorders in Nigeria during the early 21st century. Drug Alcohol Depend. 2007; 91(1):1-9.

Seme A, Mariam DH, Worku A. The association between substance abuse and HIV infection among people visiting HIV counselling and testing centres in Addis Ababa, Ethiopia. Ethiopia J Health Dev. 2005; 19(2), 116 - 25.

Hser Y, Huang Y, Teruga C, Anglin MD. Gender differences in treatment outcomes over a three-year period; a path model analysis. Journal of Drug Issues, 2004; 21:419 - 40.






Original Article